MAPT and Alzheimer disease: Importantly, we found that a BGM dysbiosis with Abx treatment delays or attenuates spatial memory impairment and total Aβ and Aβ 1-42, but not in total Tau and phosphorylated Tau in the subiculum, CA1, and CA3 at an early symptomatic stage of AD.